FIGUR8 develops a bioMotion Assessment Platform (bMAP) that utilizes wearable sensor technology to provide lab-grade biomechanics data for musculoskeletal health assessments. This technology replaces subjective measurement tools, enabling precise evaluations and personalized treatment plans that enhance recovery monitoring and improve patient outcomes.
Funding
$44.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current musculoskeletal (MSK) assessment methods often rely on subjective measurements, leading to variability in diagnoses and hindering the creation of personalized treatment plans. This lack of objective data can impede effective recovery monitoring and negatively impact patient outcomes.
Solution
FIGUR8 offers a bioMotion Assessment Platform (bMAP) that utilizes wearable sensor technology to provide objective, lab-grade biomechanics data at every point of care. By replacing subjective measurement tools, the bMAP enables precise and consistent MSK health assessments. This technology facilitates the creation of personalized care pathways, streamlines recovery monitoring, and ultimately improves patient outcomes by providing clinicians with clear, measurable data on patient progress.
Target Audience
The primary target audience includes clinicians, physical therapists, orthopedic surgeons, and workers' compensation professionals seeking objective and reliable MSK assessment tools.
Features
- Wearable sensors capture real-time biomechanics data during functional movements.
- Cloud-based analytics deliver objective metrics and reporting on MSK health.
- bioMotion Assessment Platform (bMAP) provides consistent and repeatable measurements.
- Data-driven insights support personalized treatment plans and recovery monitoring.
- Facilitates faster recovery and claims closure in workers' compensation cases.